Alkim Alkali Kimya AS (ALKIM) fair value: what the stock is really worth
We calculate from audited financials what Alkim Alkali Kimya AS is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Alkim Alkali Kimya AS for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range 6.81 TRY – 23.98 TRY · fair‑value band 4.32 TRY – 4.96 TRY · the 15.99 TRY price screens above the 4.68 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Alkim Alkali Kimya A.S., together with its subsidiaries, engages in the production and sale of paper products in Turkey. The company offers first pulp paper, coated, and photocopy paper. It also provides sodium sulphate, potassium sulphate, salt, and magnesium chloride liquid. In addition, it offers insurance brokerage services.
Show more
Alkim Alkali Kimya A.S., together with its subsidiaries, engages in the production and sale of paper products in Turkey. The company offers first pulp paper, coated, and photocopy paper. It also provides sodium sulphate, potassium sulphate, salt, and magnesium chloride liquid. In addition, it offers insurance brokerage services. The company was founded in 1948 and is headquartered in Istanbul, Turkey.
Stock analysis
Alkim Alkali Kimya AS (ALKIM) currently trades at 15.99 TRY, while our model-based Fair Value estimate is 4.68 TRY, implying the stock looks roughly 241.6% overvalued today.
Show more
Valuation
Bull case: the Dividend Discount group reads highest at a median of 17.20 TRY per share, and 2 of the 8 models we run sit above the 15.99 TRY price.
Bear case: the Earnings-Based group reads lowest at 2.90 TRY, and 6 of the 8 models stay below the price. Evidence for this calculation is low.
Scenario range: 4.32 TRY (bear) to 4.96 TRY (bull), the price of 15.99 TRY sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 24/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Alkim Alkali Kimya AS reported revenue of 5.1B TRY in FY2025 versus 1.1B TRY in FY2021, a compound +46.9%/yr. Reported net income was −408M TRY in FY2025.
Key figures
Market cap 4.8B TRY (≈ $98.8M) · P/S ratio 0.95 · EPS (TTM) −1.53 TRY · Dividend yield 7.1% · Net margin −8.0% · Return on equity −11.1% · Return on assets (EBIT) 18.4% · Operating margin −6.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 37% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 22% fair-value upside, at −71%, ALKIM screens richer than that median.
Fair Value models
Bear 4.32 TRYFair Value 4.68 TRYBull 4.96 TRY
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−16.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+46.6%
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.1%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
27.6% (2020) → 2.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Paper & Paper Products · 120 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score24 · Bottom 25%
Fair Value upside−13% · Above median
Profitability
Return on assets0% · Bottom 25%
Net margin (TTM)−9% · Bottom 25%
Operating margin (TTM)−7% · Bottom 25%
Growth and dividend
Revenue growth−7% · Bottom 25%
Dividend yield (TTM)7.1% · Top 25%
Balance sheet
Debt / equity0.02× · Lowest 25%
Valuation Multiplesvs Paper & Paper Products median · lower = cheaper
P/S (TTM)0.02× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 14
FUTURE (revenue growth)0· sector 7
PAST (return on equity)0· sector 14
HEALTH (low debt)99· sector 92
DIVIDEND (yield)0· sector 38
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Alkim Alkali Kimya AS Fair Value". https://www.fairvalue-calculator.com/stock/ALKIM
Frequently asked questions
Is Alkim Alkali Kimya AS (ALKIM) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 4.68 TRY versus a price of 15.99 TRY, about −71% upside (overvalued).
What is the fair value of ALKIM?
Our model-based fair value for Alkim Alkali Kimya AS is 4.68 TRY (as of Sep 13, 2026), built from audited fundamentals. The current price: 15.99 TRY.
What is the quality score of ALKIM?
Alkim Alkali Kimya AS has a Quality Score of 24/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Alkim Alkali Kimya AS (ALKIM)?
Our model-based price target is the fair value of 4.68 TRY (as of Sep 13, 2026) from 8 valuation models. Cautious scenario 4.32 TRY, optimistic scenario 4.96 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Alkim Alkali Kimya AS stock forecast for 2026?
Our models put fair value at 4.68 TRY, about −71% upside versus a price of 15.99 TRY (overvalued). Cautious scenario 4.32 TRY, optimistic scenario 4.96 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Alkim Alkali Kimya AS (ALKIM)?
Alkim Alkali Kimya AS reported trailing-twelve-month revenue of about 5.0B TRY (latest available figure, as of Sep 13, 2026).
Does Alkim Alkali Kimya AS pay a dividend?
Alkim Alkali Kimya AS currently shows a dividend yield of about 7.14% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of Alkim Alkali Kimya AS (ALKIM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Alkim Alkali Kimya AS it is 4.68 TRY per share (as of Sep 13, 2026), against a price of 15.99 TRY. It is the blended result of 8 valuation models (cash flow, earnings, asset, dividend).
Is Alkim Alkali Kimya AS stock overvalued or undervalued in 2026?
As of Sep 13, 2026, ALKIM trades above its calculated fair value: price 15.99 TRY, fair value 4.68 TRY, a gap of about −71% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALKIM?
No. The price is what the market pays today (15.99 TRY); the fair value is what the company's own numbers justify (4.68 TRY). For Alkim Alkali Kimya AS the two are 11.31 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Alkim Alkali Kimya AS worth?
The market values Alkim Alkali Kimya AS at about 4.8B TRY (market capitalisation, as of Sep 13, 2026). Per share that is 15.99 TRY; our models calculate a fair value of 4.68 TRY per share.
What do the bullish and bearish scenarios say about ALKIM?
Our models span a range for Alkim Alkali Kimya AS: cautious scenario 4.32 TRY, base 4.68 TRY, optimistic 4.96 TRY per share (as of Sep 13, 2026, price 15.99 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Alkim Alkali Kimya AS (ALKIM)?
Balance-sheet figures for Alkim Alkali Kimya AS (as of Sep 13, 2026): return on equity −11.1%, debt of 0.02 per unit of equity. They feed the Quality Score of 24/100, which measures business quality independently of the share price.
How far is ALKIM from its 52-week high?
Alkim Alkali Kimya AS trades at 15.99 TRY, about 37% below its 52-week high of 25.34 TRY and 3% above the low of 15.53 TRY (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 4.68 TRY is for.
Which stocks are comparable to Alkim Alkali Kimya AS?
From the same area (Basic Materials) we also value UPM-Kymmene Oyj, Suzano S.A, Svenska Cellulosa Aktiebolaget SCA (publ), Shandong Sunpaper Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Alkim Alkali Kimya AS stock attractive at the current price?
The data as of Sep 13, 2026: price 15.99 TRY, calculated fair value 4.68 TRY (−71%), Quality Score 24/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALKIM calculated?
We run Alkim Alkali Kimya AS through 8 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 4.68 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Alkim Alkali Kimya AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Alkim Alkali Kimya AS right now?
The price sits above even our optimistic bull case (4.96 TRY). The favourable scenario is already priced in. Weak quality (24/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. The models converge in a tight band (4.32 TRY to 4.96 TRY), unusually little disagreement for a valuation.
Key figures of Alkim Alkali Kimya AS
How large is the market capitalisation of Alkim Alkali Kimya AS (ALKIM)?
The market capitalisation of Alkim Alkali Kimya AS is 4.8B TRY (≈ $98.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Alkim Alkali Kimya AS (ALKIM)?
The price-to-sales ratio of Alkim Alkali Kimya AS is 0.95 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Alkim Alkali Kimya AS (ALKIM)?
Earnings per share at Alkim Alkali Kimya AS are −1.53 TRY. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Alkim Alkali Kimya AS (ALKIM)?
The dividend yield of Alkim Alkali Kimya AS is 7.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Alkim Alkali Kimya AS (ALKIM)?
The net margin of Alkim Alkali Kimya AS is −8.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Alkim Alkali Kimya AS (ALKIM)?
The return on equity (ROE) of Alkim Alkali Kimya AS is −11.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Alkim Alkali Kimya AS (ALKIM)?
On an EBIT basis the return on assets of Alkim Alkali Kimya AS is 18.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Alkim Alkali Kimya AS (ALKIM)?
The operating margin of Alkim Alkali Kimya AS is −6.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Alkim Alkali Kimya AS (ALKIM)?
Revenue at Alkim Alkali Kimya AS is growing −6.7% versus a year earlier (3y avg +22.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Alkim Alkali Kimya AS (ALKIM)?
Earnings per share at Alkim Alkali Kimya AS are growing −66.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Alkim Alkali Kimya AS (ALKIM) generate?
The free cash flow of Alkim Alkali Kimya AS is −339M TRY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Alkim Alkali Kimya AS in the live analysis
One click puts Alkim Alkali Kimya AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
